siRNA, Anti-UGT2B17, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT21832WQ-2OMe)

The product SIRGT21832WQ-2OMe is a type of small interfering RNA (siRNA) that targets UGT2B17 gene and regulates the expression of gene. The siRNA interferes with the expression of UGT2B17 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001077.3
Alternative Names BMND12; UDPGT2B17
Related Diseases Osteoporosis
Purification HPLC
Target Gene
Gene ID 7367
Uniprot ID O75795
Sub Cat Target Species Modification Scale  
SIRGT22832WQ-2F UGT2B17 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT23832WQ-2MOE UGT2B17 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT24832WQ-LNA UGT2B17 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT21832WQ-RB UGT2B17 Human Ribo-modified Inquiry
SIRGT22832WQ-BB UGT2B17 Human Backbone-modified Inquiry

Related Products